Paper 72 - OUTCOMES OF CHILDREN WITH ORBITAL RHABDOMYOSARCOMA (1991-2016): A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM (INSTRUCT)

Author(s)

• 

  Jonathan Metts, MD

  Assistant Member, Sarcoma Department
  Moffitt Cancer Center
  Tampa, Florida, United States

  Slides

Co-Author(s)

• JA

  James Anderson, PhD

  University of Nebraska Medical Center
  Omaha, Nebraska, United States
• BT

  Beate Timmermann, M.D.

  Prof.
  Westdeutsches Protonentherapiezentrum Essen (WPE), Essen, Germany
  Essen, Hessen, Germany
• Tv

  Thekla von Kalle, MD

  Klinkum Stuttgart
  Stuttgart, Baden-Wurttemberg, Germany
• MS

  Monika Sparber-Sauer, MD

  Klinkum Stuttgart
  Stuttgart, Baden-Wurttemberg, Germany
• CV

  Christian Vokuhl, MD

  Klinikum Bonn
  Bonn, Nordrhein-Westfalen, Germany
• EK

  Ewa Koscielnak, MD

  Klinkum Stuttgart
  Stuttgart, Baden-Wurttemberg, Germany
• RV

  Rajkumar Venkatramani, MD

  Texas Children's Cancer Center
  Houston, Texas, United States
• JB

  John Breneman, MD

  University of Cincinnati
  Cincinnati, Ohio, United States
• JB

  Julie Bradley, MD

  University of Florida Proton Therapy Institute
  Jacksonville, Florida, United States
• 

  Michael Arnold, MD, PhD

  Vice Chair of Anatomic Pathology and Pathology Informatics
  Colorado Children's Hospital
  Aurora, Colorado, United States
• VM

  Veronique Minard-Colin, MD

  Gustave-Roussy
  Paris, Ile-de-France, France
• GB

  Gianni Bisogno, MD, Prof

  Univeristy of Padua
  Padua, Veneto, Italy
• JM

  Johannes H.M. Merks, Prof

  Princess Máxima Center for pediatric oncology
  Utrecht, Utrecht, Netherlands
• DW

  David Walterhouse, MD

  Lurie Children's Hospital
  Chicago, Illinois, United States
• CU

  Cristian Urla, MD

  University Children’s Hospital of Tübingen
  Tübingen, Germany